nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C19—Ifosfamide—testicular cancer	0.127	0.297	CbGbCtD
Sitaxentan—CYP2C9—Ifosfamide—testicular cancer	0.106	0.247	CbGbCtD
Sitaxentan—CYP3A4—Ifosfamide—testicular cancer	0.0616	0.144	CbGbCtD
Sitaxentan—CYP2C9—Cisplatin—testicular cancer	0.0515	0.12	CbGbCtD
Sitaxentan—CYP3A4—Vinblastine—testicular cancer	0.0327	0.0762	CbGbCtD
Sitaxentan—CYP3A4—Etoposide—testicular cancer	0.0294	0.0687	CbGbCtD
Sitaxentan—CYP3A4—Doxorubicin—testicular cancer	0.0201	0.0468	CbGbCtD
Sitaxentan—Renal failure—Methotrexate—testicular cancer	0.00032	0.00056	CcSEcCtD
Sitaxentan—Dysuria—Epirubicin—testicular cancer	0.00032	0.000559	CcSEcCtD
Sitaxentan—Stomatitis—Methotrexate—testicular cancer	0.000317	0.000555	CcSEcCtD
Sitaxentan—Conjunctivitis—Methotrexate—testicular cancer	0.000317	0.000554	CcSEcCtD
Sitaxentan—Asthma—Doxorubicin—testicular cancer	0.000316	0.000553	CcSEcCtD
Sitaxentan—Pollakiuria—Epirubicin—testicular cancer	0.000316	0.000553	CcSEcCtD
Sitaxentan—Asthenia—Ifosfamide—testicular cancer	0.000315	0.000551	CcSEcCtD
Sitaxentan—Eosinophilia—Doxorubicin—testicular cancer	0.000313	0.000548	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Epirubicin—testicular cancer	0.000312	0.000546	CcSEcCtD
Sitaxentan—Feeling abnormal—Cisplatin—testicular cancer	0.000312	0.000546	CcSEcCtD
Sitaxentan—Haematuria—Methotrexate—testicular cancer	0.000311	0.000543	CcSEcCtD
Sitaxentan—Weight decreased—Epirubicin—testicular cancer	0.000309	0.000541	CcSEcCtD
Sitaxentan—Hyperglycaemia—Epirubicin—testicular cancer	0.000308	0.00054	CcSEcCtD
Sitaxentan—Somnolence—Etoposide—testicular cancer	0.000308	0.000539	CcSEcCtD
Sitaxentan—Angina pectoris—Doxorubicin—testicular cancer	0.000308	0.000539	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Methotrexate—testicular cancer	0.000308	0.000539	CcSEcCtD
Sitaxentan—Epistaxis—Methotrexate—testicular cancer	0.000307	0.000538	CcSEcCtD
Sitaxentan—Nausea—Bleomycin—testicular cancer	0.000305	0.000534	CcSEcCtD
Sitaxentan—Infestation NOS—Epirubicin—testicular cancer	0.000305	0.000533	CcSEcCtD
Sitaxentan—Infestation—Epirubicin—testicular cancer	0.000305	0.000533	CcSEcCtD
Sitaxentan—Vomiting—Dactinomycin—testicular cancer	0.000305	0.000533	CcSEcCtD
Sitaxentan—Bronchitis—Doxorubicin—testicular cancer	0.000304	0.000532	CcSEcCtD
Sitaxentan—Rash—Dactinomycin—testicular cancer	0.000302	0.000529	CcSEcCtD
Sitaxentan—Decreased appetite—Etoposide—testicular cancer	0.000301	0.000527	CcSEcCtD
Sitaxentan—Diarrhoea—Ifosfamide—testicular cancer	0.0003	0.000526	CcSEcCtD
Sitaxentan—Pancytopenia—Doxorubicin—testicular cancer	0.0003	0.000526	CcSEcCtD
Sitaxentan—Renal failure—Epirubicin—testicular cancer	0.0003	0.000524	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Etoposide—testicular cancer	0.000299	0.000524	CcSEcCtD
Sitaxentan—Body temperature increased—Cisplatin—testicular cancer	0.000299	0.000524	CcSEcCtD
Sitaxentan—Fatigue—Etoposide—testicular cancer	0.000299	0.000523	CcSEcCtD
Sitaxentan—Stomatitis—Epirubicin—testicular cancer	0.000297	0.00052	CcSEcCtD
Sitaxentan—Jaundice—Epirubicin—testicular cancer	0.000297	0.00052	CcSEcCtD
Sitaxentan—Pain—Etoposide—testicular cancer	0.000297	0.000519	CcSEcCtD
Sitaxentan—Constipation—Etoposide—testicular cancer	0.000297	0.000519	CcSEcCtD
Sitaxentan—Conjunctivitis—Epirubicin—testicular cancer	0.000296	0.000518	CcSEcCtD
Sitaxentan—Dysuria—Doxorubicin—testicular cancer	0.000296	0.000518	CcSEcCtD
Sitaxentan—Haemoglobin—Methotrexate—testicular cancer	0.000294	0.000514	CcSEcCtD
Sitaxentan—Hepatitis—Methotrexate—testicular cancer	0.000292	0.000512	CcSEcCtD
Sitaxentan—Haemorrhage—Methotrexate—testicular cancer	0.000292	0.000512	CcSEcCtD
Sitaxentan—Pollakiuria—Doxorubicin—testicular cancer	0.000292	0.000511	CcSEcCtD
Sitaxentan—Haematuria—Epirubicin—testicular cancer	0.000291	0.000508	CcSEcCtD
Sitaxentan—Dizziness—Ifosfamide—testicular cancer	0.00029	0.000508	CcSEcCtD
Sitaxentan—Urinary tract disorder—Methotrexate—testicular cancer	0.000289	0.000505	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000289	0.000505	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Epirubicin—testicular cancer	0.000288	0.000504	CcSEcCtD
Sitaxentan—Epistaxis—Epirubicin—testicular cancer	0.000287	0.000503	CcSEcCtD
Sitaxentan—Urethral disorder—Methotrexate—testicular cancer	0.000287	0.000501	CcSEcCtD
Sitaxentan—Weight decreased—Doxorubicin—testicular cancer	0.000286	0.000501	CcSEcCtD
Sitaxentan—Sinusitis—Epirubicin—testicular cancer	0.000286	0.0005	CcSEcCtD
Sitaxentan—Feeling abnormal—Etoposide—testicular cancer	0.000286	0.0005	CcSEcCtD
Sitaxentan—Hyperglycaemia—Doxorubicin—testicular cancer	0.000285	0.000499	CcSEcCtD
Sitaxentan—Nausea—Dactinomycin—testicular cancer	0.000285	0.000498	CcSEcCtD
Sitaxentan—Infestation—Doxorubicin—testicular cancer	0.000282	0.000493	CcSEcCtD
Sitaxentan—Infestation NOS—Doxorubicin—testicular cancer	0.000282	0.000493	CcSEcCtD
Sitaxentan—Visual impairment—Methotrexate—testicular cancer	0.000282	0.000493	CcSEcCtD
Sitaxentan—Vomiting—Ifosfamide—testicular cancer	0.000279	0.000488	CcSEcCtD
Sitaxentan—Hypersensitivity—Cisplatin—testicular cancer	0.000279	0.000488	CcSEcCtD
Sitaxentan—Bradycardia—Epirubicin—testicular cancer	0.000279	0.000487	CcSEcCtD
Sitaxentan—Renal failure—Doxorubicin—testicular cancer	0.000277	0.000485	CcSEcCtD
Sitaxentan—Rash—Ifosfamide—testicular cancer	0.000277	0.000484	CcSEcCtD
Sitaxentan—Dermatitis—Ifosfamide—testicular cancer	0.000277	0.000484	CcSEcCtD
Sitaxentan—Urticaria—Etoposide—testicular cancer	0.000275	0.000482	CcSEcCtD
Sitaxentan—Haemoglobin—Epirubicin—testicular cancer	0.000275	0.000481	CcSEcCtD
Sitaxentan—Stomatitis—Doxorubicin—testicular cancer	0.000275	0.000481	CcSEcCtD
Sitaxentan—Jaundice—Doxorubicin—testicular cancer	0.000275	0.000481	CcSEcCtD
Sitaxentan—Rhinitis—Epirubicin—testicular cancer	0.000274	0.00048	CcSEcCtD
Sitaxentan—Body temperature increased—Etoposide—testicular cancer	0.000274	0.00048	CcSEcCtD
Sitaxentan—Conjunctivitis—Doxorubicin—testicular cancer	0.000274	0.00048	CcSEcCtD
Sitaxentan—Haemorrhage—Epirubicin—testicular cancer	0.000274	0.000479	CcSEcCtD
Sitaxentan—Hepatitis—Epirubicin—testicular cancer	0.000274	0.000479	CcSEcCtD
Sitaxentan—Eye disorder—Methotrexate—testicular cancer	0.000273	0.000478	CcSEcCtD
Sitaxentan—Tinnitus—Methotrexate—testicular cancer	0.000273	0.000477	CcSEcCtD
Sitaxentan—Asthenia—Cisplatin—testicular cancer	0.000272	0.000475	CcSEcCtD
Sitaxentan—Cardiac disorder—Methotrexate—testicular cancer	0.000271	0.000475	CcSEcCtD
Sitaxentan—Urinary tract disorder—Epirubicin—testicular cancer	0.00027	0.000473	CcSEcCtD
Sitaxentan—Oedema peripheral—Epirubicin—testicular cancer	0.00027	0.000472	CcSEcCtD
Sitaxentan—Haematuria—Doxorubicin—testicular cancer	0.000269	0.000471	CcSEcCtD
Sitaxentan—Urethral disorder—Epirubicin—testicular cancer	0.000268	0.000469	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000267	0.000467	CcSEcCtD
Sitaxentan—Epistaxis—Doxorubicin—testicular cancer	0.000266	0.000465	CcSEcCtD
Sitaxentan—Angiopathy—Methotrexate—testicular cancer	0.000265	0.000464	CcSEcCtD
Sitaxentan—Sinusitis—Doxorubicin—testicular cancer	0.000265	0.000463	CcSEcCtD
Sitaxentan—Immune system disorder—Methotrexate—testicular cancer	0.000264	0.000462	CcSEcCtD
Sitaxentan—Visual impairment—Epirubicin—testicular cancer	0.000264	0.000461	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methotrexate—testicular cancer	0.000263	0.000461	CcSEcCtD
Sitaxentan—Nausea—Ifosfamide—testicular cancer	0.000261	0.000456	CcSEcCtD
Sitaxentan—Diarrhoea—Cisplatin—testicular cancer	0.000259	0.000453	CcSEcCtD
Sitaxentan—Alopecia—Methotrexate—testicular cancer	0.000258	0.000452	CcSEcCtD
Sitaxentan—Bradycardia—Doxorubicin—testicular cancer	0.000258	0.000451	CcSEcCtD
Sitaxentan—Mental disorder—Methotrexate—testicular cancer	0.000256	0.000448	CcSEcCtD
Sitaxentan—Eye disorder—Epirubicin—testicular cancer	0.000256	0.000447	CcSEcCtD
Sitaxentan—Hypersensitivity—Etoposide—testicular cancer	0.000255	0.000447	CcSEcCtD
Sitaxentan—Tinnitus—Epirubicin—testicular cancer	0.000255	0.000446	CcSEcCtD
Sitaxentan—Malnutrition—Methotrexate—testicular cancer	0.000255	0.000445	CcSEcCtD
Sitaxentan—Haemoglobin—Doxorubicin—testicular cancer	0.000254	0.000445	CcSEcCtD
Sitaxentan—Cardiac disorder—Epirubicin—testicular cancer	0.000254	0.000444	CcSEcCtD
Sitaxentan—Flushing—Epirubicin—testicular cancer	0.000254	0.000444	CcSEcCtD
Sitaxentan—Rhinitis—Doxorubicin—testicular cancer	0.000254	0.000444	CcSEcCtD
Sitaxentan—Haemorrhage—Doxorubicin—testicular cancer	0.000253	0.000443	CcSEcCtD
Sitaxentan—Hepatitis—Doxorubicin—testicular cancer	0.000253	0.000443	CcSEcCtD
Sitaxentan—Urinary tract disorder—Doxorubicin—testicular cancer	0.00025	0.000437	CcSEcCtD
Sitaxentan—Oedema peripheral—Doxorubicin—testicular cancer	0.000249	0.000436	CcSEcCtD
Sitaxentan—Asthenia—Etoposide—testicular cancer	0.000249	0.000435	CcSEcCtD
Sitaxentan—Angiopathy—Epirubicin—testicular cancer	0.000248	0.000434	CcSEcCtD
Sitaxentan—Urethral disorder—Doxorubicin—testicular cancer	0.000248	0.000434	CcSEcCtD
Sitaxentan—Immune system disorder—Epirubicin—testicular cancer	0.000247	0.000432	CcSEcCtD
Sitaxentan—Mediastinal disorder—Epirubicin—testicular cancer	0.000247	0.000431	CcSEcCtD
Sitaxentan—Visual impairment—Doxorubicin—testicular cancer	0.000244	0.000427	CcSEcCtD
Sitaxentan—Alopecia—Epirubicin—testicular cancer	0.000242	0.000423	CcSEcCtD
Sitaxentan—Vomiting—Cisplatin—testicular cancer	0.000241	0.000421	CcSEcCtD
Sitaxentan—Mental disorder—Epirubicin—testicular cancer	0.00024	0.000419	CcSEcCtD
Sitaxentan—Rash—Cisplatin—testicular cancer	0.000239	0.000418	CcSEcCtD
Sitaxentan—Dermatitis—Cisplatin—testicular cancer	0.000238	0.000417	CcSEcCtD
Sitaxentan—Malnutrition—Epirubicin—testicular cancer	0.000238	0.000417	CcSEcCtD
Sitaxentan—Diarrhoea—Etoposide—testicular cancer	0.000237	0.000415	CcSEcCtD
Sitaxentan—Eye disorder—Doxorubicin—testicular cancer	0.000237	0.000414	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methotrexate—testicular cancer	0.000236	0.000413	CcSEcCtD
Sitaxentan—Tinnitus—Doxorubicin—testicular cancer	0.000236	0.000413	CcSEcCtD
Sitaxentan—Anaemia—Methotrexate—testicular cancer	0.000235	0.000412	CcSEcCtD
Sitaxentan—Flushing—Doxorubicin—testicular cancer	0.000235	0.000411	CcSEcCtD
Sitaxentan—Cardiac disorder—Doxorubicin—testicular cancer	0.000235	0.000411	CcSEcCtD
Sitaxentan—Tension—Epirubicin—testicular cancer	0.000234	0.000409	CcSEcCtD
Sitaxentan—Nervousness—Epirubicin—testicular cancer	0.000231	0.000405	CcSEcCtD
Sitaxentan—Angiopathy—Doxorubicin—testicular cancer	0.00023	0.000402	CcSEcCtD
Sitaxentan—Malaise—Methotrexate—testicular cancer	0.00023	0.000402	CcSEcCtD
Sitaxentan—Dizziness—Etoposide—testicular cancer	0.000229	0.000401	CcSEcCtD
Sitaxentan—Muscle spasms—Epirubicin—testicular cancer	0.000229	0.000401	CcSEcCtD
Sitaxentan—Immune system disorder—Doxorubicin—testicular cancer	0.000229	0.0004	CcSEcCtD
Sitaxentan—Vertigo—Methotrexate—testicular cancer	0.000229	0.0004	CcSEcCtD
Sitaxentan—Mediastinal disorder—Doxorubicin—testicular cancer	0.000228	0.000399	CcSEcCtD
Sitaxentan—Leukopenia—Methotrexate—testicular cancer	0.000228	0.000399	CcSEcCtD
Sitaxentan—Nausea—Cisplatin—testicular cancer	0.000225	0.000393	CcSEcCtD
Sitaxentan—Alopecia—Doxorubicin—testicular cancer	0.000224	0.000391	CcSEcCtD
Sitaxentan—Mental disorder—Doxorubicin—testicular cancer	0.000222	0.000388	CcSEcCtD
Sitaxentan—Ill-defined disorder—Epirubicin—testicular cancer	0.000221	0.000387	CcSEcCtD
Sitaxentan—Vomiting—Etoposide—testicular cancer	0.00022	0.000386	CcSEcCtD
Sitaxentan—Malnutrition—Doxorubicin—testicular cancer	0.00022	0.000386	CcSEcCtD
Sitaxentan—Anaemia—Epirubicin—testicular cancer	0.00022	0.000385	CcSEcCtD
Sitaxentan—Agitation—Epirubicin—testicular cancer	0.000219	0.000383	CcSEcCtD
Sitaxentan—Rash—Etoposide—testicular cancer	0.000219	0.000383	CcSEcCtD
Sitaxentan—Dermatitis—Etoposide—testicular cancer	0.000218	0.000382	CcSEcCtD
Sitaxentan—Headache—Etoposide—testicular cancer	0.000217	0.00038	CcSEcCtD
Sitaxentan—Chest pain—Methotrexate—testicular cancer	0.000217	0.000379	CcSEcCtD
Sitaxentan—Tension—Doxorubicin—testicular cancer	0.000216	0.000378	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000215	0.000377	CcSEcCtD
Sitaxentan—Malaise—Epirubicin—testicular cancer	0.000215	0.000376	CcSEcCtD
Sitaxentan—Discomfort—Methotrexate—testicular cancer	0.000214	0.000375	CcSEcCtD
Sitaxentan—Nervousness—Doxorubicin—testicular cancer	0.000214	0.000375	CcSEcCtD
Sitaxentan—Vertigo—Epirubicin—testicular cancer	0.000214	0.000374	CcSEcCtD
Sitaxentan—Leukopenia—Epirubicin—testicular cancer	0.000213	0.000373	CcSEcCtD
Sitaxentan—Muscle spasms—Doxorubicin—testicular cancer	0.000212	0.000371	CcSEcCtD
Sitaxentan—Confusional state—Methotrexate—testicular cancer	0.000209	0.000366	CcSEcCtD
Sitaxentan—Infection—Methotrexate—testicular cancer	0.000206	0.000361	CcSEcCtD
Sitaxentan—Nausea—Etoposide—testicular cancer	0.000206	0.00036	CcSEcCtD
Sitaxentan—Ill-defined disorder—Doxorubicin—testicular cancer	0.000204	0.000358	CcSEcCtD
Sitaxentan—Nervous system disorder—Methotrexate—testicular cancer	0.000204	0.000356	CcSEcCtD
Sitaxentan—Anaemia—Doxorubicin—testicular cancer	0.000204	0.000356	CcSEcCtD
Sitaxentan—Thrombocytopenia—Methotrexate—testicular cancer	0.000203	0.000356	CcSEcCtD
Sitaxentan—Chest pain—Epirubicin—testicular cancer	0.000203	0.000355	CcSEcCtD
Sitaxentan—Agitation—Doxorubicin—testicular cancer	0.000203	0.000354	CcSEcCtD
Sitaxentan—Skin disorder—Methotrexate—testicular cancer	0.000202	0.000353	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000201	0.000352	CcSEcCtD
Sitaxentan—Discomfort—Epirubicin—testicular cancer	0.0002	0.000351	CcSEcCtD
Sitaxentan—Malaise—Doxorubicin—testicular cancer	0.000199	0.000348	CcSEcCtD
Sitaxentan—Dry mouth—Epirubicin—testicular cancer	0.000198	0.000347	CcSEcCtD
Sitaxentan—Vertigo—Doxorubicin—testicular cancer	0.000198	0.000346	CcSEcCtD
Sitaxentan—Anorexia—Methotrexate—testicular cancer	0.000198	0.000346	CcSEcCtD
Sitaxentan—Leukopenia—Doxorubicin—testicular cancer	0.000197	0.000345	CcSEcCtD
Sitaxentan—Confusional state—Epirubicin—testicular cancer	0.000196	0.000343	CcSEcCtD
Sitaxentan—Oedema—Epirubicin—testicular cancer	0.000194	0.00034	CcSEcCtD
Sitaxentan—Hypotension—Methotrexate—testicular cancer	0.000194	0.00034	CcSEcCtD
Sitaxentan—Infection—Epirubicin—testicular cancer	0.000193	0.000338	CcSEcCtD
Sitaxentan—Nervous system disorder—Epirubicin—testicular cancer	0.000191	0.000334	CcSEcCtD
Sitaxentan—Thrombocytopenia—Epirubicin—testicular cancer	0.00019	0.000333	CcSEcCtD
Sitaxentan—Tachycardia—Epirubicin—testicular cancer	0.00019	0.000332	CcSEcCtD
Sitaxentan—Skin disorder—Epirubicin—testicular cancer	0.000189	0.00033	CcSEcCtD
Sitaxentan—Insomnia—Methotrexate—testicular cancer	0.000188	0.000329	CcSEcCtD
Sitaxentan—Chest pain—Doxorubicin—testicular cancer	0.000188	0.000328	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000186	0.000326	CcSEcCtD
Sitaxentan—Discomfort—Doxorubicin—testicular cancer	0.000185	0.000324	CcSEcCtD
Sitaxentan—Anorexia—Epirubicin—testicular cancer	0.000185	0.000324	CcSEcCtD
Sitaxentan—Somnolence—Methotrexate—testicular cancer	0.000185	0.000323	CcSEcCtD
Sitaxentan—Dry mouth—Doxorubicin—testicular cancer	0.000183	0.000321	CcSEcCtD
Sitaxentan—Dyspepsia—Methotrexate—testicular cancer	0.000183	0.00032	CcSEcCtD
Sitaxentan—Hypotension—Epirubicin—testicular cancer	0.000182	0.000318	CcSEcCtD
Sitaxentan—Confusional state—Doxorubicin—testicular cancer	0.000181	0.000317	CcSEcCtD
Sitaxentan—Decreased appetite—Methotrexate—testicular cancer	0.000181	0.000316	CcSEcCtD
Sitaxentan—Oedema—Doxorubicin—testicular cancer	0.00018	0.000315	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000179	0.000314	CcSEcCtD
Sitaxentan—Fatigue—Methotrexate—testicular cancer	0.000179	0.000313	CcSEcCtD
Sitaxentan—Infection—Doxorubicin—testicular cancer	0.000179	0.000313	CcSEcCtD
Sitaxentan—Pain—Methotrexate—testicular cancer	0.000178	0.000311	CcSEcCtD
Sitaxentan—Nervous system disorder—Doxorubicin—testicular cancer	0.000176	0.000309	CcSEcCtD
Sitaxentan—Thrombocytopenia—Doxorubicin—testicular cancer	0.000176	0.000308	CcSEcCtD
Sitaxentan—Insomnia—Epirubicin—testicular cancer	0.000176	0.000308	CcSEcCtD
Sitaxentan—Tachycardia—Doxorubicin—testicular cancer	0.000176	0.000307	CcSEcCtD
Sitaxentan—Skin disorder—Doxorubicin—testicular cancer	0.000175	0.000306	CcSEcCtD
Sitaxentan—Somnolence—Epirubicin—testicular cancer	0.000173	0.000302	CcSEcCtD
Sitaxentan—Anorexia—Doxorubicin—testicular cancer	0.000171	0.0003	CcSEcCtD
Sitaxentan—Feeling abnormal—Methotrexate—testicular cancer	0.000171	0.0003	CcSEcCtD
Sitaxentan—Dyspepsia—Epirubicin—testicular cancer	0.000171	0.000299	CcSEcCtD
Sitaxentan—Decreased appetite—Epirubicin—testicular cancer	0.000169	0.000296	CcSEcCtD
Sitaxentan—Hypotension—Doxorubicin—testicular cancer	0.000168	0.000294	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000168	0.000294	CcSEcCtD
Sitaxentan—Fatigue—Epirubicin—testicular cancer	0.000168	0.000293	CcSEcCtD
Sitaxentan—Pain—Epirubicin—testicular cancer	0.000166	0.000291	CcSEcCtD
Sitaxentan—Constipation—Epirubicin—testicular cancer	0.000166	0.000291	CcSEcCtD
Sitaxentan—Urticaria—Methotrexate—testicular cancer	0.000165	0.000289	CcSEcCtD
Sitaxentan—Body temperature increased—Methotrexate—testicular cancer	0.000164	0.000287	CcSEcCtD
Sitaxentan—Insomnia—Doxorubicin—testicular cancer	0.000163	0.000285	CcSEcCtD
Sitaxentan—Feeling abnormal—Epirubicin—testicular cancer	0.00016	0.00028	CcSEcCtD
Sitaxentan—Somnolence—Doxorubicin—testicular cancer	0.00016	0.00028	CcSEcCtD
Sitaxentan—Dyspepsia—Doxorubicin—testicular cancer	0.000158	0.000277	CcSEcCtD
Sitaxentan—Decreased appetite—Doxorubicin—testicular cancer	0.000156	0.000274	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000155	0.000272	CcSEcCtD
Sitaxentan—Fatigue—Doxorubicin—testicular cancer	0.000155	0.000271	CcSEcCtD
Sitaxentan—Urticaria—Epirubicin—testicular cancer	0.000154	0.00027	CcSEcCtD
Sitaxentan—Pain—Doxorubicin—testicular cancer	0.000154	0.000269	CcSEcCtD
Sitaxentan—Constipation—Doxorubicin—testicular cancer	0.000154	0.000269	CcSEcCtD
Sitaxentan—Body temperature increased—Epirubicin—testicular cancer	0.000154	0.000269	CcSEcCtD
Sitaxentan—Hypersensitivity—Methotrexate—testicular cancer	0.000153	0.000268	CcSEcCtD
Sitaxentan—Asthenia—Methotrexate—testicular cancer	0.000149	0.000261	CcSEcCtD
Sitaxentan—Feeling abnormal—Doxorubicin—testicular cancer	0.000148	0.000259	CcSEcCtD
Sitaxentan—Hypersensitivity—Epirubicin—testicular cancer	0.000143	0.000251	CcSEcCtD
Sitaxentan—Urticaria—Doxorubicin—testicular cancer	0.000143	0.00025	CcSEcCtD
Sitaxentan—Body temperature increased—Doxorubicin—testicular cancer	0.000142	0.000249	CcSEcCtD
Sitaxentan—Diarrhoea—Methotrexate—testicular cancer	0.000142	0.000249	CcSEcCtD
Sitaxentan—Asthenia—Epirubicin—testicular cancer	0.000139	0.000244	CcSEcCtD
Sitaxentan—Dizziness—Methotrexate—testicular cancer	0.000137	0.00024	CcSEcCtD
Sitaxentan—Diarrhoea—Epirubicin—testicular cancer	0.000133	0.000233	CcSEcCtD
Sitaxentan—Hypersensitivity—Doxorubicin—testicular cancer	0.000133	0.000232	CcSEcCtD
Sitaxentan—Vomiting—Methotrexate—testicular cancer	0.000132	0.000231	CcSEcCtD
Sitaxentan—Rash—Methotrexate—testicular cancer	0.000131	0.000229	CcSEcCtD
Sitaxentan—Dermatitis—Methotrexate—testicular cancer	0.000131	0.000229	CcSEcCtD
Sitaxentan—Headache—Methotrexate—testicular cancer	0.00013	0.000228	CcSEcCtD
Sitaxentan—Asthenia—Doxorubicin—testicular cancer	0.000129	0.000226	CcSEcCtD
Sitaxentan—Dizziness—Epirubicin—testicular cancer	0.000129	0.000225	CcSEcCtD
Sitaxentan—Vomiting—Epirubicin—testicular cancer	0.000124	0.000216	CcSEcCtD
Sitaxentan—Nausea—Methotrexate—testicular cancer	0.000123	0.000216	CcSEcCtD
Sitaxentan—Diarrhoea—Doxorubicin—testicular cancer	0.000123	0.000215	CcSEcCtD
Sitaxentan—Rash—Epirubicin—testicular cancer	0.000123	0.000214	CcSEcCtD
Sitaxentan—Dermatitis—Epirubicin—testicular cancer	0.000122	0.000214	CcSEcCtD
Sitaxentan—Headache—Epirubicin—testicular cancer	0.000122	0.000213	CcSEcCtD
Sitaxentan—Dizziness—Doxorubicin—testicular cancer	0.000119	0.000208	CcSEcCtD
Sitaxentan—Nausea—Epirubicin—testicular cancer	0.000115	0.000202	CcSEcCtD
Sitaxentan—Vomiting—Doxorubicin—testicular cancer	0.000114	0.0002	CcSEcCtD
Sitaxentan—Rash—Doxorubicin—testicular cancer	0.000113	0.000198	CcSEcCtD
Sitaxentan—Dermatitis—Doxorubicin—testicular cancer	0.000113	0.000198	CcSEcCtD
Sitaxentan—Headache—Doxorubicin—testicular cancer	0.000113	0.000197	CcSEcCtD
Sitaxentan—Nausea—Doxorubicin—testicular cancer	0.000107	0.000187	CcSEcCtD
